BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Nosology, Phenobarbital, rs2300478, IL1A, calcium channel activity, Ischemia)
Bookmark Forward

QuickView for mTOR (gene)


Body Atlas

Most Correlated Tissues

  1. Ciliary ganglion
  2. Macrophage of peripheral blood
  3. Superior cervical ganglion
  4. Testes
  5. Atrioventricular node
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Macrocephaly
  2. Bordetellosis
  3. Neurological finding
  4. Rhinitis
  5. Microbial culture finding
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. N-acetylsphingosine
  2. Carbenoxolone
  3. Lithocholic Acid
  4. dyclonine
  5. Dizocilpine Maleate
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. hsa-miR-365a-3p
  2. CYTOR
  3. YBX2
  4. DDX25
  5. SOX7
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Evaluation of Akt and RICTOR Expression Levels in Astrocytomas of All Grades.
  2. Tor1 and CK2 kinases control a switch between alternative ribosome biogenesis pathways in a growth-d…
  3. mTOR has distinct functions in generating versus sustaining humoral immunity.
  4. Aspirin disrupts the mTOR-Raptor complex and potentiates the anti-cancer activities of sorafenib via…
  5. Statistical evaluation of DPPH, ABTS, FRAP, and Folin-Ciocalteu assays to assess the antioxidant cap…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Leucine, mTOR and Athero
  2. Using mTOR Inhibitors in the Prevention of BK Nephropathy
  3. mTOR and Adipose Tissue Inflammation
  4. Efficacy of Everolimus-containing Chemotherapy in HER2- mBC Patients With PI3K/AKT/mTOR Mutations St…
  5. Expanded Access for ABI-009 in Patients With Advanced PEComa and Patients With a Malignancy With Rel…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.